Haymarket Media launched the site PsychiatryAdvisor.com today.
Researchers are increasingly using social media to recruit patients, albeit oftentimes in an arms-length manner.
Guidance on promoting products in 140 characters and correcting misinformation serves as a guarded green light, says one observer.
Texting HCPs may be speedy, but a study finds some built-in risks.
The Omnicom-Publicis deal may have been scuttled, but the hunger for deals remains.
The AIDS Healthcare Foundation took out an ad in some WSJ editions saying the drug threatens to "break the bank."
Praised for helping navigate the shift by advertisers into digital, media vet Kim Kadlec is leaving pharma for a new role at AOL.
Express Scripts notes that these prescriptions may not, in fact, be for ADHD.
The FDA's proposed upgrade to its off-label distribution guidelines has some new features, but experts say it is unclear if this means more dollars will flow toward reprints.
A month after UBM Canon closed the B2B magazine, marketing firm Outcomes LLC announced its return to twice-a-year publication.
The agency says outlets need to rethink running ads that make false claims.
Our year-end list captures the 10 that sparked heaviest interest.
The move to digitize a series of books it co-created with Disney for kids with type 1 diabetes was spurred by a meeting with the online diabetes community.
Elsevier is taking a hard-line posture against several different universities, asking them to take down scholarly research.
The Heath, Labor and Welfare ministry says a publisher passed off advertorials as articles.
EHRs could be a vehicle for pharma to find its way into the physician's workflow. First, industry needs to learn how to leverage them appropriately.
American Medical News's 55-year publishing history ended September 2, although the website will be maintained through the end of the year.
A research team found that Big Pharma has pulled back on publications despite doubling or even quadrupling research and development budgets
The company has partnered with Univision on a dance competition that supports health and weight loss. The segment, called Ritmo Dieta, will run for 13 weeks on the variety program Sábado Gigante.
For women suffering from breast cancer, online tools appeared to be helpful in battling depression, a randomized trial showed.
News on JAMA Ophthalmology, the New England Journal of Medicine, Elsevier and Oxford University Press
A study published in JAMA Internal Medicine shows that encouraging patients to read up on a topic beforehand could make office visits more productive
MedPage Today's new VP and global editorial director, Ivan Oransky, has a goal in mind: to make the resource even more top-of-mind among the medical community by broadening and deepening its content and engagement
Remedy Health is hoping a new design for its flagship portal can give it an edge over rivals WebMD and Everyday Health.
American Medical News' 55-year publishing run will come to a close this year, the AMA, its publisher, said today.
David Schlanger is the company's new chief executive, a role he's filled on an interim basis since May.
Patient use of the professional app prompted the latest iteration, and the foundation behind it is set to launch a media push.
The ad watchdog flagged the drug maker for what it said was yet another misleading Ampyra promotional piece.
News on Scientific Communications Group, Elsevier and the American Medical Association
DeepDyve has expanded its content-streaming service to allow users to look at entire articles for five minutes, after which they can choose from several purchase or rental options
A refreshed version of the Omino app will be viewable in both portrait and landscape modes, as well as including a variety of other new features
Reuters Health's former executive editor has plans for cultivating a broader, richer experience for MedPage Today readers. He's already got a list of writers he's looking to recruit.
News on Oxford University Press, Barash's Clinical Anesthesia and UBM Medica
Professional physician network Doximity hit two milestones this spring: membership hit 160,000 US physicians and the network released an iPad app that will help doctors better leverage the network
Velcade has rolled out an "iPatient" sales app to help invigorate the brand
News on the American Diabetes Association, MedCity News, UBM Medica and the American College of Physicians
Wiley announced in March that it will enter 2014 with at least 66 new titles under its umbrella
Elsevier is replacing its OncologyStat portal with a multidisciplinary news and research aggregator called PracticeUpdate
Doctors call out Novartis on drug prices; Aubagio shows strong top-line data in trials; and overseas docs increasingly turn to digital.
News on Wiley, Journal of the Academy of Nutrition and Dietetics, and the American Psychiatric Nurses Association
Medical publisher and news source JAMA Network's latest launch—the JAMA Network Reader—is finding new ways to engage readers and advertisers
Members of newly formed American Association of Nurse Pracitioners will receive the journals of both groups that merged to form it
News on Current Psychiatry, BIoMed Central, Elsevier and Wiley
A piece in open-access journal PLOS that highlights problems with the current state of published clinical trial data.
Industry observances of Rare Disease Awareness Day are getting more elaborate of late—perhaps not solely for altruistic reasons, as a third of NMEs approved by FDA over the past five years were for the treatment of rare diseases.
Allergan's 2013 outlook scores points with at least one analyst, Amgen is laying off 160 staff, and Wiley renews a publishing relationship.
News on Time Inc., WIley and Wolters Kluwer Health
Cloud-based electronic health-record and practice-management provider Athenahealth is buying mobile health firm Epocrates for $293 million in cash
A new Elsevier marketing campaign consists of two mobile units that bring an immersive experience to institutions and individuals
Healthcare PR giant Dan Edelman dies; Pfizer says 'no comment' on breakup speculation; Publicis Healthcare snags a new SVP; Lippincott gives nurses a new drug diagnosis tool.
Publicis Healthcare Communications Group is retooling its media offering, placing media talent at each of its shops and creating a centralized media hub for execution.
What changes in marketing or audience viewing habits might impact pharma's media investment this year? Media buyers weigh in on the hot channel trends.
News on the Wall Street Journal, Nature and Elsevier
Monthly Prescribing Reference has unveiled a redesign—its first since 2009.
Data from three publication groups indicate that it's still too soon for publishers to ditch print for digital-only publications,
News on Wiley, Nature Publishing Group and the American Society of Plastic Surgeons
Starting next year, the BMJ will not publish academic papers on drugs or devices unless the relevant anonymized patient-level data are made available for third-party study.
Nonprofit National Bureau of Economic Research—the organization that officially declares the stop and start of recessions—has issued a report that adds another angle to the recent data about journal retraction rates.
The amount of revenue pharma leaves on the table due to non-adherence is much more than previously thought, a new study suggests.
Studies show that printed pieces still hold sway in the industry.
News on Lippincott;s Surgical Review Library App, Health Communications and Elsevier
MM&M sister publication Clinical Advisor launched an app September 25 that has already captured more than 92,000 page views and almost 20,000 app launches.
A study published by the Proceedings of the National Academy of Science found that 43.4% of retracted articles were pulled over false and fabricated data or suspicion of fraud
For the big mainline ad agencies, the recent creative consolidations at Pfizer and Johnson & Johnson are a big deal, but to their medical agency subsidiaries, they mostly represent a codification of where things stood to begin with.
News on Wolters Kluwer, Contraception magazine, the Crohn's and Colitis Foundation and Elsevier
Health marketing communications firm Enspektos did a deep dive into desktop and media habits and found that who you are in the healthcare industry plays a big role in how much you trust the information that pops up on the screen.
The size of JAMA's audience is giving the Super Bowl a run for its money
The advent of new ad-unit lengths is bringing drugmakers much-needed relief from the high cost of advertising on television.
WebMD executed a cross-platform magazine redesign with a more visual and celeb-centric new look.
News on Elsevier, Springer and The International Journal of Angiology
Nine Journal of the American Medical Associaiton publications will get new names in 2013
The medical journal publisher says advertisers are following the move toward the iPad
The fan base of the AMA's publishing arm grew 115% in the second quarter.
Novo snags 46% of the insulin market, Merck delays its cholesterol drug, and Remedy Health and HealthiNation sign a video distribution pact.
News on Quadrant Health, Springer Science + Business Media, and The American Journal of Preventive Medicine
The American Heart Association's publications are now fully mobile.
In an effort to shore up their reputations, pharma and professional publishers have crafted an accountability plan.
WorldOne has acquired Sermo, adding the physician social network's 130,000-strong physician community to its own global network of 1.7 million healthcare professionals.
News on DMD , Elsevier and Springer
JAMA is focusing more attention on its Viewpoint feature, in which the editor chooses a topic, picks a panel of experts and pits them against each another in print
An email from Harvard University's Faculty Advisory Council over the cost of professional journals has touched off the latest round in the universities vs publishers sparring match.
Journals are a curious media form in that they provide fodder for debate on medical topics, but not a forum in which to hold one. Enter JAMA's new Viewpoint feature.
News on Thieme, MedPage Today and Nature Publishing Group
Science and media publisher Springer is unrolling a new platform for its corporate clients called Springer R&D.
The diabetes crisis and the amount of research connected to the disease is prompting publisher Elsevier to increase the heft and frequency of its Journal of Diabetes and its Complications.
News on Elsevier, MPR and EMBO Molecular Medicine
ASCPT launches its first fully open-access publication, and Wiley-Blackwell adds 44 journals
The FDA approval of 23-mg donepezil (Aricept) conflicted with the opinions of its own reviewers and breached the agency's own regulatory standard, authors write in a BMJ article, leading to misleading consumer and physician ad campaigns that put patients at risk.
GlaxoSmithKline is building its first new UK factory in almost 40 years, the firm said, spurring jobs while breaking new ground at some of its current locations.
WebMD the Magazine is now part of the iPad app world.
News about Jobson Medical Information Holdings, Medical Prescribing Reference, DTW Research Marketing Group and Communications Media Inc./Compas
Open-access research project F1000 has launched a program in which submissions are published following an "initial sanity check" from the project's director of new product development
Glenn Kolansky, Board Certified Dermatologist, Adv. Dermatology Surgery & Laser Center, Red Bank, NJ.
An online protest has pulled the scientific publishing industry, and particularly Dutch publisher Elsevier, into a tug of war with writers.
Publicis Groupe is expanding its footprint in China, having acquired the healthcare communications agency U-Link Solutions Co. Ltd.
Jobson Medical Information Holdings filed for chapter 11 bankruptcy in New York Thursday, the company said, part of an effort to amend and extend its credit and strengthen its balance sheet.
Procter & Gamble is looking to lower its promotion costs by leaning more on digital media, Chairman and CEO Bob McDonald told analysts in an earnings call.
An online protest, which had more than 2,500 supporters as of Wednesday morning, has pulled the scientific publishing industry into a fight between the publishers and the published.